Basolateral amygdala CB1 cannabinoid receptors mediate nicotine-induced place preference

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Nicotine addiction is a significant public health issue.
• The basolateral amygdala (BLA) plays a role in reward processing.
• The endogenous cannabinoid system is implicated in drug reward.

Purpose of the Study:

• To investigate the role of cannabinoid CB1 receptors in the BLA on nicotine-induced place preference.
• To examine the effects of cannabinoid agonists and antagonists administered into the BLA on nicotine reward.

Main Methods:

• Adult male Wistar rats were used in a conditioned place preference (CPP) paradigm.
• Bilateral microinjections of cannabinoid CB1 receptor agonist (WIN 55,212-2) and antagonist (AM251) into the BLA were performed.
• Effects on locomotor activity were assessed to control for non-specific drug effects.

Main Results:

• Intra-BLA administration of a CB1 agonist (WIN 55,212-2) with an ineffective dose of nicotine induced place preference.
• Intra-BLA administration of a CB1 antagonist (AM251) inhibited the acquisition of nicotine-induced place preference.
• AM251, but not WIN 55,212-2, inhibited the expression of nicotine-induced place preference without affecting locomotor activity.

Conclusions:

• The endogenous cannabinoid system in the BLA is involved in both the acquisition and expression of nicotine-induced place preference.
• There is a functional interaction between BLA cannabinoid receptors and nicotine in mediating rewarding effects.
• Targeting BLA cannabinoid receptors may offer a novel therapeutic strategy for nicotine addiction.